SCHEMBL3743799

SCHEMBL3743799

O=[N+]([O-])[C@H]1CC(CO)=C(c2ccccc2)C[C@@H]1c1ccc(Cl)cc1Cl

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.37
HTT P42858 1/20 0.37
DPP4 P27487 7/20 0.36
HTR2A P28223 1/20 0.34
HTR2C P28335 1/20 0.34
HTR2B P41595 1/20 0.34
HPD P32754 2/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
TRPM5 Q9NZQ8 2/20 0.32
TRPM4 Q8TD43 1/20 0.32
FFAR2 O15552 1/20 0.32
ENPP2 Q13822 1/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
EDNRB P24530 1/20 0.31
EDNRA P25101 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3743804 1.00 ALDH1A1 (0.37) ALDH1A1HTTDPP4HTR2AHTR2C
SCHEMBL3743810 1.00 ALDH1A1 (0.37) ALDH1A1HTTDPP4HTR2AHTR2C
SCHEMBL3745198 0.88 ALDH1A1 (0.38) ALDH1A1HTTSMN1; SMN2TRPM5MEN1
SCHEMBL3745186 0.88 ALDH1A1 (0.38) ALDH1A1HTTSMN1; SMN2TRPM5MEN1
SCHEMBL3745194 0.88 ALDH1A1 (0.38) ALDH1A1HTTSMN1; SMN2TRPM5MEN1
SCHEMBL3750706 0.82 HTR2A (0.36) DPP4HTR2AHTR2CHTR2BTRPM5
SCHEMBL3750710 0.82 HTR2A (0.36) DPP4HTR2AHTR2CHTR2BTRPM5
SCHEMBL3750708 0.82 HTR2A (0.36) DPP4HTR2AHTR2CHTR2BTRPM5
SCHEMBL3744945 0.80 MAOB (0.34) ALDH1A1HTT
SCHEMBL3744938 0.80 MAOB (0.34) ALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1919854-B1 PHARMACEUTICAL COMPOSITIONS AS INHIBITORS OF DIPEPTIDYL PEPTIDASE-IV (DPP-IV) ABBVIE INC (US) 2013-09-18 EP disclosed
US-7834012-B2 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV) ABBOTT LABORATORIES (US) 2010-11-16 US disclosed
US-20070049596-A1 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV) ABBVIE INC. 2007-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070049596-A1 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV) DPP4, DPP3, DPP7 ALDH1A1 1841/4885HTT 2696/4885DPP4 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.